Fred Burke Sells 671,432 Shares of Guardian Pharmacy Services (NYSE:GRDN) Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Fred Burke sold 671,432 shares of the stock in a transaction on Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $19,928,101.76. Following the transaction, the insider owned 840,413 shares of the company’s stock, valued at approximately $24,943,457.84. This represents a 44.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Guardian Pharmacy Services Trading Down 3.0%

Shares of NYSE:GRDN opened at $35.41 on Friday. The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of 45.98 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a 12-month low of $19.17 and a 12-month high of $38.12. The business has a 50-day moving average price of $32.74 and a 200 day moving average price of $29.91.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.10. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The company had revenue of $397.62 million during the quarter, compared to analyst estimates of $390.04 million. The business’s revenue for the quarter was up 17.4% on a year-over-year basis. As a group, equities research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Guardian Pharmacy Services News Roundup

Here are the key news stories impacting Guardian Pharmacy Services this week:

• Positive Sentiment: Q3 / latest quarter: GRDN beat EPS and revenue estimates (revenue +17.4% YoY), which supports growth expectations. MarketBeat GRDN summary
• Positive Sentiment: Analyst momentum: several firms (Truist, Raymond James, Oppenheimer, Stephens, Zacks) have raised targets or ratings recently, leaving a buy/strong-buy consensus and a ~$38 average target. Analyst coverage
• Neutral Sentiment: Institutional holders: several funds (Vanguard, Wellington, Brown Advisory, Franklin, Valiant) have recently adjusted positions; this shows continuing institutional interest but mixed flows. Holders data
• Neutral Sentiment: Market writeups flagged “major insider exodus,” useful for context but not new filings by itself. TipRanks article
• Negative Sentiment: Director Thomas J. Salentine, Jr. sold 3,570,677 shares at ~$29.68 (~$106.0M), a ~44% reduction — a large block that likely pressured the stock. SEC filing
• Negative Sentiment: Director William E. Bindley sold 3,570,677 shares at ~$29.68 (~$106.0M), a ~44% reduction — another very large director sale. SEC filing
• Negative Sentiment: Director John Ackerman sold 1,103,364 shares at ~$29.68 (~$32.7M), a ~76% reduction in his stake. SEC filing
• Negative Sentiment: Officer Fred Burke sold 671,432 shares at ~$29.68 (~$19.9M), a ~44% cut to his position. SEC filing
• Negative Sentiment: Insider Kendall Forbes sold 346,672 shares at ~$29.68 (~$10.3M), reducing her holding by ~43%. SEC filing
• Negative Sentiment: Insider David K. Morris sold 187,855 shares at ~$29.68 (~$5.6M), cutting his position by ~42%. SEC filing
• Negative Sentiment: Major shareholder Equity Fund L.P. (Cardinal) sold 275,728 shares at ~$29.68 (~$8.2M), a ~44% stake reduction — signals significant institutional unloading. SEC filing

Hedge Funds Weigh In On Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue acquired a new position in shares of Guardian Pharmacy Services during the third quarter worth about $30,000. Ameritas Investment Partners Inc. raised its holdings in Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after acquiring an additional 345 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Guardian Pharmacy Services in the second quarter valued at approximately $43,000. Police & Firemen s Retirement System of New Jersey lifted its stake in Guardian Pharmacy Services by 76.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after acquiring an additional 1,062 shares during the last quarter. Finally, State of Wyoming acquired a new position in Guardian Pharmacy Services during the 2nd quarter worth approximately $58,000.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Stephens upped their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 14th. Raymond James Financial restated an “outperform” rating and set a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Truist Financial raised their target price on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Finally, Oppenheimer lifted their target price on Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $38.00.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.